Human Vaccines & Immunotherapeutics: News

Mostrar otras versiones (9)

Agenus reports increased survival rates for its brain cancer vaccine First vaccines developed for avian influenza A H7N9 virus Ovarian cancer vaccine shows promise in early clinical trial  No increased risk of GBS following vaccination Heroin vaccine blocks relapse in animal study New pediatric vacc...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Editor's Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901805/
http://dx.doi.org/10.4161/hv.25576
Descripción
Sumario:Agenus reports increased survival rates for its brain cancer vaccine First vaccines developed for avian influenza A H7N9 virus Ovarian cancer vaccine shows promise in early clinical trial  No increased risk of GBS following vaccination Heroin vaccine blocks relapse in animal study New pediatric vaccine approved in Europe Safe antigen delivery: Engineered type-III secretion system in bacterial mini-cells Universal influenza T-cell vaccine effective in an elderly population

Ejemplares similares